South Africa has suspended giving Johnson & Johnson vaccine shots as a precautionary measure following an FDA decision to pause using the jabs while blood clot cases are examined.
Health Minister Dr. Zweli Mkhize said South Africa was halting the use of J&J jabs with the expectation that the questions over the J&J vaccine should be cleared within a matter of days.
Addressing reporters, Mkhize stated that the country has given more than 289,000 jabs of the J&J vaccine to the country’s health workers without any reports of blood clots.
Earlier, Johnson & Johnson said it was delaying the rollout of its vaccine across Europe following a U.S. probe, into reported cases of blood clots. The move appears to be further shaking vaccine confidence and complicating COVID-19 immunization efforts.
Regulators in the United States said they were recommending a pause in the single-dose shot to investigate reports of rare but potentially dangerous blood clots.
In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were investigating six cases of unusual clots which occurred six to 13 days after vaccination with the J&J shot.
Discover more from LN247
Subscribe to get the latest posts sent to your email.
